Feb 14, 2023 | FDA, Featured
Patients Rising Now submitted comments to the Food and Drug Administration (FDA) on making naloxone available as an over-the-counter treatment. Naloxone is a treatment which prevents death in the event of an opioid overdose and is currently only available through...
Read more
Feb 13, 2023 | Featured, Letters Supported
Patients Rising Now joined 58 other organizations in a letter sent to the Centers for Medicare and Medicaid (CMS) on reinstating a Federal Rule prohibiting step therapy in Medicare Advantage plans. In 2012, CMS instituted a prohibition on step therapy in Medicare...
Read more
Feb 10, 2023 | Featured, QALY, Uncategorized
Patients Rising Now sent a letter to the Equal Employment Opportunity Commission (EEOC) regarding the release of its draft Strategic Enforcement Plan (SEP). The draft SEP outlined several new policy changes to enhance protections for employees from vulnerable...
Read more
Feb 7, 2023 | Comment Letters
Patients Rising Now joined 70 other patients groups in a letter to the Centers for Medicare and Medicaid Services (CMS) on the expansion of the Low Income Subsidy (LIS). As part of the Inflation Reduction Act (IRA), the LIS was expanded to include beneficiaries who...
Read more
Feb 2, 2023 | Featured Action, QALY
The House Energy and Commerce (E&C) Health Subcommittee held a hearing on banning the use of the Quality-Adjusted Life Year (QALY) in Federal health programs. The Protecting Health Care for All Patients Act (H.R.485) was recently reintroduced by Chairwoman Rodgers...
Read more
